LawIllustrative imageNational transposition of the MDR (Germany, MPDG)
Example of a member-state law that accompanies the MDR: it sets national competent-authority powers, clinical investigation oversight and language requirements for the German market.
European regulations apply directly, but member states still adopt national legislation to designate competent authorities, define enforcement powers and set requirements that the EU framework leaves to national discretion. In Germany this role is filled by the Medizinprodukterecht-Durchführungsgesetz.
National provisions typically cover the language of instructions for use and labelling, the notification of domestic manufacturing sites, and the procedures for market surveillance carried out by the competent authority. They also frame how clinical investigations performed in the country are reviewed and monitored.
For companies operating across several member states this means that a compliant EU technical file is necessary but not always sufficient: local language, registration and vigilance contact requirements must be checked market by market.
This entry is an illustrative summary. The binding text is the version published in the national official journal, together with any implementing ordinances issued by the competent authority.
Important: this page is an editorial summary for demonstration purposes. It is not legal advice and does not replace the official text. Always rely on the consolidated version published in the Official Journal of the EU and on qualified regulatory advice.